Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy
- PMID: 11458053
Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy
Abstract
Purpose: The role of radical cystectomy in patients with nonmuscle invasive urothelial carcinoma of the bladder remains controversial. The risk of overtreatment must be balanced against the potential benefit of aggressive therapy. We reviewed our results in these patients with a particular emphasis on clinical under staging.
Materials and methods: We reviewed the records of 214 consecutive patients who underwent radical cystectomy for urothelial carcinoma between April 1995 and August 1999, focusing on those with nonmuscle invasive, stages T1 or less disease. We assessed clinical and pathological data as well as outcomes based on pathological disease extent.
Results: A total of 78 patients (36%) underwent radical cystectomy for clinical stages T1 or less disease. Indications included disease refractory to intravesical therapy in 29 cases (37%), pathological findings reflective of high grade stage T1 or multifocal disease in 26 (33%), radiographic suspicion of invasive disease in 15 (20%) and severe symptoms in 8 (10%). Cancer was clinically under staged with stages pT2 or greater disease in 31 patients (40%) according to final pathology results. Under staging was most pronounced in the 10 patients (67%) with suspicious radiography and in the 18 (64%) with absent muscle in the biopsy specimen. Of the 78 patients with pathological stages pT1 disease or less 98% had no evidence of disease compared to 65% with stages pT2 or greater disease (p <0.01).
Conclusions: Despite the intent to perform early cystectomy a significant percent of patients harbored occult muscle invasive and/or metastatic disease. In clinical and pathological, superficial stages T1 or less cases disease-free survival was excellent. Due to these results, the selection of high risk superficial transitional cell carcinoma cases for continued bladder sparing treatment should include uninvolved muscle on biopsy and absent radiographic suspicion of invasion.
Similar articles
-
Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.J Urol. 2006 Aug;176(2):493-8; discussion 498-9. doi: 10.1016/j.juro.2006.03.065. J Urol. 2006. PMID: 16813876
-
Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients.J Urol. 2010 May;183(5):1757-63. doi: 10.1016/j.juro.2010.01.025. Epub 2010 Mar 17. J Urol. 2010. PMID: 20299059
-
The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.BJU Int. 2004 Dec;94(9):1258-62. doi: 10.1111/j.1464-410X.2004.05228.x. BJU Int. 2004. PMID: 15610101
-
[Analysis of 34 cases of infiltrating carcinoma of the bladder treated exclusively with partial cystectomy (part 1)].Arch Esp Urol. 1996 May;49(4):349-64. Arch Esp Urol. 1996. PMID: 8754191 Review. Spanish.
-
Invasive T1 bladder cancer: indications and rationale for radical cystectomy.BJU Int. 2008 Aug;102(3):270-5. doi: 10.1111/j.1464-410X.2008.07743.x. Epub 2008 May 20. BJU Int. 2008. PMID: 18494831 Review.
Cited by
-
Predictive value of pretreatment inflammation-based prognostic scores (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio) for invasive bladder carcinoma.Korean J Urol. 2015 Nov;56(11):749-55. doi: 10.4111/kju.2015.56.11.749. Epub 2015 Nov 3. Korean J Urol. 2015. PMID: 26568792 Free PMC article.
-
Immune therapies in non-muscle invasive bladder cancer.Curr Treat Options Oncol. 2015 Feb;16(2):5. doi: 10.1007/s11864-014-0315-3. Curr Treat Options Oncol. 2015. PMID: 25757877 Review.
-
Management of T1 Urothelial Carcinoma of the Bladder: What Do We Know and What Do We Need To Know?Bladder Cancer. 2015 Sep 5;2(1):1-14. doi: 10.3233/BLC-150022. Bladder Cancer. 2015. PMID: 27376120 Free PMC article. Review.
-
Effect of Intravesical Bacilli Calmette-Guerin Therapy After Second Transurethral Resection in Stage Ta T1 High-Grade Bladder Cancer.Yonago Acta Med. 2019 Jun 20;62(2):191-197. doi: 10.33160/yam.2019.06.003. eCollection 2019 Jun. Yonago Acta Med. 2019. PMID: 31320823 Free PMC article.
-
Impact of concomitant carcinoma in situ on upstaging and outcome following radical cystectomy for bladder cancer.World J Urol. 2014 Oct;32(5):1295-301. doi: 10.1007/s00345-013-1207-z. Epub 2013 Nov 10. World J Urol. 2014. PMID: 24213922
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous